share_log

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

China Pharma (NYSE:CPHI) Research Coverage Started at StockNews.com

中國製藥股份有限公司（紐約證交所代碼：CPHI）研究覆蓋率開始於證券新聞網
Financial News Live ·  2023/01/19 01:41

StockNews.com started coverage on shares of China Pharma (NYSE:CPHI – Get Rating) in a research report released on Monday. The firm issued a hold rating on the stock.

證券新聞網開始對股票的報導 中國製藥公司（紐約證券交易所代碼：CPHI — 獲得評級） 在星期一發布的研究報告中。該公司對股票發出了持有評級。

China Pharma Price Performance

中國製藥價格表現

Shares of CPHI opened at $0.11 on Monday. China Pharma has a 1-year low of $0.08 and a 1-year high of $0.53. The stock has a market cap of $5.43 million, a PE ratio of -1.31 and a beta of 0.69. The firm has a 50-day simple moving average of $0.11 and a two-hundred day simple moving average of $0.16.

CPHI 的股份在星期一以 0.11 美元開盤。中國製藥有 1 年低點 0.08 美元和 1 年新高 0.53 美元。該股的市值為 543 萬美元，私募股票比率為 -1.31，貝塔值為 0.69。該公司擁有一個 50 天的簡單移動平均線 0.11 美元和 200 天的簡單移動平均線 0.16 美元。

Get
取得
China Pharma
中國製藥
alerts:
警報：

About China Pharma

關於中國醫藥

(Get Rating)

(取得評分)

China Pharma Holdings, Inc engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products.
中國醫藥控股有限公司從事醫藥產品的開發，製造和銷售。該公司的產品組合包括中樞神經系統（CNS）和腦心血管疾病，抗感染和呼吸系統疾病，消化系統疾病，綜合醫療保健和防護產品。

Featured Stories

特色故事

  • Get a free copy of the StockNews.com research report on China Pharma (CPHI)
  • Procter & Gamble Earnings: A Gamble Worth Taking
  • Stocks Slide, Economic Report Paints Gloomy Picture For Economy
  • What does Nu Holdings Stock Have To Do With Warren Buffett?
  • J.B. Hunt Gets A Flat, Logistic Companies Come Into Focus
  • Is Intel Stock On The Verge Of Breaking Out?
  • 獲取有關中國醫藥研究報告的免費副本
  • 寶潔公司的收益：值得參加的賭博
  • 股票幻燈片，經濟報告描繪經濟陰沉的圖片
  • NU 控股股票與沃倫·巴菲特有什麼關係？
  • J.B. 亨特得到一個單位, 物流公司成為焦點
  • 英特爾股票是否瀕臨爆發？

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

接收《中國醫藥日報》的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收有關中國製藥及相關公司的最新新聞和分析師評級的簡要每日摘要。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論